202 related articles for article (PubMed ID: 31384890)
1. Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.
Lofti-Jam KL; O'Reilly CL; Feng CS; Wakefield MA; Durkin S; Broun KH
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384890
[TBL] [Abstract][Full Text] [Related]
2. Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.
Durkin SJ; Broun K; Spittal MJ; Wakefield MA
BMJ Open; 2019 Jan; 9(1):e024267. PubMed ID: 30813110
[TBL] [Abstract][Full Text] [Related]
3. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
[TBL] [Abstract][Full Text] [Related]
4. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
5. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
[TBL] [Abstract][Full Text] [Related]
6. The National Bowel Cancer Screening Program: time to achieve its potential to save lives.
Ee H; St John J
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384889
[TBL] [Abstract][Full Text] [Related]
7. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
[TBL] [Abstract][Full Text] [Related]
9. Factors contributing to low readiness and capacity of culturally diverse participants to use the Australian national bowel screening kit.
Phillipson L; Pitts L; Hall J; Tubaro T
Public Health Res Pract; 2019 Mar; 29(1):. PubMed ID: 30972408
[TBL] [Abstract][Full Text] [Related]
10. Impact of a mass media campaign on participation in the Australian bowel cancer screening program.
Durkin S; Broun K; Guerin N; Morley B; Wakefield M
J Med Screen; 2020 Mar; 27(1):18-24. PubMed ID: 31530160
[TBL] [Abstract][Full Text] [Related]
11. Equity of colorectal cancer screening: which groups have inequitable participation and what can we do about it?
Ward PR; Javanparast S; Wilson C
Aust J Prim Health; 2011; 17(4):334-46. PubMed ID: 22112702
[TBL] [Abstract][Full Text] [Related]
12. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
McIntosh JG; Jenkins M; Wood A; Chondros P; Campbell T; Wenkart E; O'Reilly C; Dixon I; Toner J; Martinez-Gutierrez J; Govan L; Emery JD
Br J Gen Pract; 2024 Apr; 74(741):e275-e282. PubMed ID: 38164588
[TBL] [Abstract][Full Text] [Related]
13. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
14. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
15. Cancer screening education: can it change knowledge and attitudes among culturally and linguistically diverse communities in Queensland, Australia?
Cullerton K; Gallegos D; Ashley E; Do H; Voloschenko A; Fleming M; Ramsey R; Gould T
Health Promot J Austr; 2016 Jun; 27(2):140-147. PubMed ID: 27376437
[No Abstract] [Full Text] [Related]
16. Beliefs about bowel cancer among the target group for the National Bowel Cancer Screening Program in Australia.
Jalleh G; Donovan RJ; Lin C; Slevin T; Clayforth C; Pratt IS; Ledger M
Aust N Z J Public Health; 2010 Apr; 34(2):187-92. PubMed ID: 23331364
[TBL] [Abstract][Full Text] [Related]
17. Australia's national bowel cancer screening program: does it work for indigenous Australians?
Christou A; Katzenellenbogen JM; Thompson SC
BMC Public Health; 2010 Jun; 10():373. PubMed ID: 20579344
[TBL] [Abstract][Full Text] [Related]
18. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
19. Trust, choice and obligation: a qualitative study of enablers of colorectal cancer screening in South Australia.
Ward PR; Coffey C; Meyer S
Sociol Health Illn; 2015 Sep; 37(7):988-1006. PubMed ID: 25912247
[TBL] [Abstract][Full Text] [Related]
20. Engaging lower screening groups: a field experiment to evaluate the impact of a multiwave national campaign on participation in the National Bowel Cancer Screening Program.
Gascoyne C; Broun K; Morley B; Wyatt K; Feletto E; Durkin SJ
BMJ Open; 2023 Mar; 13(3):e065124. PubMed ID: 36921953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
